Close Menu
Business Voice NowBusiness Voice Now
    Facebook X (Twitter) Instagram
    Business Voice NowBusiness Voice Now
    Subscribe
    • Markets
      • BFSI
      • Capital Goods
    • Business
      • FMCG
      • Retail
      • Quick Commerce
      • Startups
    • Healthcare
    • Technology
    • Energy
    • Voices
      • Entrepreneur – CXO Stories
      • Corporate Office story
    • E Magazine
      • Year 2026
        • August 2026
        • July 2026
    Business Voice NowBusiness Voice Now
    Home»Business»Rupus Global Limited infuses academic researchers on Board, inducts top strategists in Advisory Board – Primex News Network
    Business

    Rupus Global Limited infuses academic researchers on Board, inducts top strategists in Advisory Board – Primex News Network

    By April 28, 2022No Comments3 Mins Read
    Share Facebook Twitter Pinterest LinkedIn Tumblr Email
    Follow Us
    Google News Flipboard Threads
    Share
    Facebook Twitter LinkedIn Pinterest Email

    Prof. Solomon Darwin

     New Delhi (India), April 28: World renowned Academician Prof. Solomon Darwin , Director, UC Berkeley-Haas Center for Corporate Innovation & Network 7 Media Group Chief Dr Satya Brahma to guide Rupus Global Limited.

    Hong Kong.  Rupus Global Limited, the Hong Kong based pharmaceutical Company today announced the induction of noted & eminent global researchers as advisors to the board of directors. Prof. Solomon Darwin, Director, UC Berkeley-Haas Center for Corporate Innovation, Executive Director, Center for Growth Markets & Dr. Satya Brahma, author columnist & founder chairman of Network 7 Media Group will be guiding & advising the Rupus Global Board of Directors in building Rupus as a strong international pharmaceutical company in its pursuit to its mission to widen its academic excellence.

    Announcing the appointment of two seasoned academic researchers as Advisors, {Prof} Dr. Kannan Vishwanatth, Managing Director of Rupus Global Limited said “We are pleased to announce Prof. Solomon Darwin & Dr Satya Brahma on our Board. We can’t wait to see how our highly experienced board members will  enlighten us to develop the vision and purpose of building Rupus Global Limited in the market by advising on matters of strategic importance, leverage decades of top-tier industry experience, broaden and deepen our relationships, and ensure continued growth and success.

    Prof. Solomon Darwin hailed as the “Father of the Smart Village Movement” has broad leadership experience in corporate management and academia. He is an international speaker recognized by peers, executives, and students with numerous awards for his innovative leadership and passion for teaching.

    He inspires students from both business and engineering disciplines in his courses for open innovation, business models, smart cities, scalable smart villages, and business models for emerging economies. He is also known as the father of the Smart Village Movement. As an expert in “open innovation” and “open business models,” he is an adviser to senior executives of multinationals and government leaders in the emerging world.. Before joining Berkeley Haas in 2005, he was an Associate Professor for nine years at the University of Southern California.

    During summers, Prof Darwin regularly teaches in executive programs at prominent international universities and institutions. He has conducted workshops and programs in over 18 countries. His current projects, “Building Scalable Smart Villages” and “The Rebuilding India Initiative” were commissioned by the government of India.

    Dr. Satya Brahma is a noted author & research analyst. Dr Satya is the founder chairman of Network 7 Media Group, Asia’s most acclaimed research media firm engaged in timely, in-depth analysis of companies, industries, markets, and world economies.

    Dr Satya Brahma is also the author of many top books including the best selling Truth VS Hype. Dr Satya Brahma is most respected & distinguished journalist & known for championing the cause of Citizen’s rights & free speech. Dr. Satya holds a Master’s degree in Political science with First Class First Gold Medalist from Berhampur University & Master’s degree in Journalism & Mass Communications.

    RUPUS GLOBAL LIMITED is a research-focused vertically integrated pharmaceutical Company, which Contract manufactures active pharmaceutical ingredients and is in contract research and manufacturing services (CRAMS). The Company is a market leader in the Antimalarial API segment and is the world’s third-largest contract manufacturer of Quinine salts. It also exports its products to more than 60 emerging countries in Africa, Central and South America, and Asia.

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

    Related Posts

    Deendayal Port Authority, Kandla organised the Kandla Green Hydrogen Conclave 2026 at Gandhidham (Gujarat)

    August 24, 2026

    Dr Vritika Agrawal Sets Her Sights on Building Dermacute into a New-Age Beauty, Healthcare & Wellness Enterprise

    August 24, 2026

    Magellanic Cloud’s Provigil Surveillance Wins ₹7.92 Crore LOA from Western Railway, Ratlam Division, for Level Crossing Gate Surveillance and Telecom

    August 24, 2026

    Comments are closed.

    Recent Post
    • The Rise of Usage of AI for Interview Cheating. How Candidates are Gaming Virtual Interviews?
    • Deendayal Port Authority, Kandla organised the Kandla Green Hydrogen Conclave 2026 at Gandhidham (Gujarat)
    • From Little Astral Star Kid to Little Mr. Universe: 8-Year-Old Kiaan Mahendrakar Creates History for India
    • Dr Vritika Agrawal Sets Her Sights on Building Dermacute into a New-Age Beauty, Healthcare & Wellness Enterprise
    • Dr. Kathan Talsania Explains How Ahmedabad Can Become the World’s Next Hub for Robotic Joint Replacement and Arthroscopy
    • Magellanic Cloud’s Provigil Surveillance Wins ₹7.92 Crore LOA from Western Railway, Ratlam Division, for Level Crossing Gate Surveillance and Telecom
    • Railway Board Chairman Reviews IRCTC’s Central War Room in Delhi, Praises Strong Monitoring and Food Quality Check
    • Davangere Sugar Shares: Analyst Note Sees 234% Upside to ₹10 Target Amid Sugar Cycle Tailwinds

    Type above and press Enter to search. Press Esc to cancel.